APA (7th ed.) Citation

Watanabe, S., Tsubouchi, I., & Okubo, A. (2018). Efficacy and safety of fosravuconazole L‐lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double‐blind, randomized phase III study. Journal of dermatology, 45(10), 1151-1159. https://doi.org/10.1111/1346-8138.14607

Chicago Style (17th ed.) Citation

Watanabe, Shinichi, Ichiro Tsubouchi, and Akihiro Okubo. "Efficacy and Safety of Fosravuconazole L‐lysine Ethanolate, a Novel Oral Triazole Antifungal Agent, for the Treatment of Onychomycosis: A Multicenter, Double‐blind, Randomized Phase III Study." Journal of Dermatology 45, no. 10 (2018): 1151-1159. https://doi.org/10.1111/1346-8138.14607.

MLA (9th ed.) Citation

Watanabe, Shinichi, et al. "Efficacy and Safety of Fosravuconazole L‐lysine Ethanolate, a Novel Oral Triazole Antifungal Agent, for the Treatment of Onychomycosis: A Multicenter, Double‐blind, Randomized Phase III Study." Journal of Dermatology, vol. 45, no. 10, 2018, pp. 1151-1159, https://doi.org/10.1111/1346-8138.14607.